BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11925154)

  • 1. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
    Hohenfellner R; Höckel M
    Gynecol Oncol; 2002 Apr; 85(1):227. PubMed ID: 11925154
    [No Abstract]   [Full Text] [Related]  

  • 2. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
    Silver DF; Ashwell TR
    Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
    Husain A; Curtin J; Brown C; Chi D; Hoskins W; Poynor E; Alektiar K; Barakat R
    Gynecol Oncol; 2000 Aug; 78(2):208-11. PubMed ID: 10926804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary diversion after anterior or total exenteration in advanced tumors of the female genitals].
    Stein R
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):M45-50. PubMed ID: 8682276
    [No Abstract]   [Full Text] [Related]  

  • 6. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies.
    Urh A; Soliman PT; Schmeler KM; Westin S; Frumovitz M; Nick AM; Fellman B; Urbauer DL; Ramirez PT
    Gynecol Oncol; 2013 Jun; 129(3):580-5. PubMed ID: 23480870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Karsenty G; Moutardier V; Lelong B; Guiramand J; Houvenaeghel G; Delpero JR; Bladou F
    Gynecol Oncol; 2005 May; 97(2):524-8. PubMed ID: 15863155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possibilities and operative aspects of gynecologic urologic interventions in the treatment of malignant diseases of the pelvic organs].
    Ackermann R
    Gynakologe; 1985 Mar; 18(1):26-34. PubMed ID: 4007630
    [No Abstract]   [Full Text] [Related]  

  • 9. Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?
    Martínez A; Filleron T; Vitse L; Querleu D; Mery E; Balague G; Delannes M; Soulie M; Pomel C; Ferron G
    Gynecol Oncol; 2011 Mar; 120(3):374-9. PubMed ID: 21215437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies.
    Ramirez PT; Modesitt SC; Morris M; Edwards CL; Bevers MW; Wharton JT; Wolf JK
    Gynecol Oncol; 2002 May; 85(2):285-91. PubMed ID: 11972389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
    Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New gynecologic surgery techniques and methods in oncology].
    Villet R; Ercoli A; Salet-Lizee D; Dargent D; Morice P; Gadonneix P; Leblanc E
    Bull Cancer; 2001 Jan; 88(1):101-7. PubMed ID: 11182659
    [No Abstract]   [Full Text] [Related]  

  • 13. [Operative mortality and morbidity in pelvic exenteration. Technical aspects].
    De Ranieri J; Crouet H; André M; Souloy J; Desdoits JM; Bouvet A
    J Chir (Paris); 1986 Apr; 123(4):246-50. PubMed ID: 3745309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary diversion after pelvic exenteration for gynecologic malignancies.
    Martínez-Gómez C; Angeles MA; Martinez A; Malavaud B; Ferron G
    Int J Gynecol Cancer; 2021 Jan; 31(1):1-10. PubMed ID: 33229410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
    Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
    Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of 108 exenteration operations in advanced gynecologic cancers].
    Friedberg V
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):423-7. PubMed ID: 2472302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the automatic stapler in urinary conduit diversions and pelvic exenterations.
    Delgado G
    Gynecol Oncol; 1980 Aug; 10(1):93-7. PubMed ID: 7399334
    [No Abstract]   [Full Text] [Related]  

  • 18. Exenterative surgery.
    Vergote IB
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):25-8. PubMed ID: 9090478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urologic complications of pelvic exenteration for gynecologic malignancy.
    Fallon B; Loening S; Hawtrey CE; Lifshitz SG; Buchsbaum HJ
    J Urol; 1979 Aug; 122(2):158-9. PubMed ID: 459005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopy-assisted vaginal pelvic exenteration.
    Ferron G; Querleu D; Martel P; Letourneur B; Soulié M
    Gynecol Oncol; 2006 Mar; 100(3):551-5. PubMed ID: 16249020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.